Epilepsy & Medical Cannabis: Epidiolex FDA Guide | ZenWeedGuide

CANNABINOIDS

CBD (Epidiolex FDA)

EVIDENCE LEVEL

FDA Approved

MEDICAL ACCESS

All US States (CBD)

APPROVED SINCE

2018 (Epidiolex)

How CBD Reduces Seizures

Medical cannabis for Epilepsy — Cannabis-based treatments are increasingly accessible for Epilepsy patients worldwide.

CBD's antiseizure mechanisms are distinct from traditional anticonvulsants. CBD modulates GPR55 receptors (desensitisation reduces neuronal excitability), inhibits sodium channels, and enhances adenosine signalling — all contributing to seizure threshold elevation. Unlike THC, CBD does not cause psychoactive effects, making it safe for children and patients requiring full cognitive function. Charlotte's Web — developed specifically for Charlotte Figi's Dravet syndrome — catalysed the CBD epilepsy movement. Understanding how CBD works in the nervous system is essential for families navigating paediatric epilepsy treatment. Consult the ECS guide for the neurobiological mechanism.

Clinical Evidence & Research

The pivotal Epidiolex trials demonstrated 39% median reduction in convulsive seizures versus placebo in Dravet syndrome patients. For Lennox-Gastaut syndrome, Epidiolex reduced drop seizures by 44% versus placebo. A 2017 NEJM study — the highest-quality evidence — confirmed CBD's efficacy in treatment-resistant childhood epilepsy. Real-world data from the Expanded Access Programme showed consistent seizure reduction in 84% of patients across a range of refractory epilepsy syndromes. Germany and several EU countries have approved Epidiolex through their standard drug approval processes.

Access & Patient Requirements

CBD is federally legal in the US, and Epidiolex is available in all 50 states as a prescription medication. State medical cannabis programmes additionally cover whole-plant cannabis preparations for patients over 18. For paediatric patients, Epidiolex is the appropriate pharmaceutical-grade option. California, Colorado, and New York have broad epilepsy qualifying criteria for adult medical cannabis. Neurologist involvement is typically required for paediatric cases.

Recommended Cannabis Approaches for Epilepsy

Pharmaceutical-grade CBD (Epidiolex) is the standard of care for paediatric treatment-resistant epilepsy (Dravet, LGS). For adult patients, high-potency CBD oil (200-600mg daily) is the evidence-based approach. Consistent daily dosing is critical — seizure threshold maintenance requires stable CBD blood levels. Do not use high-THC cannabis for epilepsy without specialist guidance, as THC can lower seizure threshold in some patients. CBD bioavailability is improved when taken with high-fat meals. The linalool terpene has additional anticonvulsant properties documented in animal models.

Research & Further Reading

Frequently Asked Questions

Is CBD FDA-approved for epilepsy?

Yes. Epidiolex (pharmaceutical-grade CBD) received FDA approval in 2018 for Dravet syndrome and Lennox-Gastaut syndrome — two severe treatment-resistant epilepsy syndromes. It is the first plant-derived, FDA-approved drug and represents the strongest regulatory endorsement of any cannabinoid.

How much CBD is needed to control seizures?

Clinical trials used 10-20mg/kg/day CBD (Epidiolex). For adults, typical clinical doses range 200-600mg daily. Start low and titrate every 2 weeks under neurologist supervision. Bioavailability is increased with food. Consistent daily dosing is essential — missed doses can trigger seizure breakthrough.

Can cannabis cure epilepsy?

Cannabis does not cure epilepsy but can dramatically reduce seizure frequency and severity. 39-44% median seizure reduction was demonstrated in Epidiolex trials. Approximately 5% of patients in clinical trials became seizure-free. For many treatment-resistant patients, this represents a transformative improvement in quality of life.

Is THC safe for people with epilepsy?

THC's effects on seizure threshold are complex and individual. Some patients tolerate low-dose THC without issue, while others find it lowers their seizure threshold. CBD is the preferred cannabinoid for epilepsy. High-THC cannabis should not be used for epilepsy without specialist neurologist guidance.

What epilepsy syndromes does cannabis treat?

The strongest evidence is for Dravet syndrome and Lennox-Gastaut syndrome (both FDA-approved for Epidiolex). Clinical research also supports CBD for CDKL5 deficiency disorder, Aicardi syndrome, and other refractory childhood epilepsies. Adult focal epilepsy and temporal lobe epilepsy are also studied, with promising preliminary results.

Epilepsy & Medical Cannabis